Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
Kotak Healthcare Fund Reg (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 11-Dec-23
Corpus(Cr.) 768.00 Latest NAV 16.547 As on 29-10-2026
Equity(%) 98.69 52 Week High 17.431
Debt(%) 1.31 52 Week Low 12.593
Others(%) 0.00 Exit Load 0.5% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark NIFTY Healthcare TRI. Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Dhananjay Tikariha
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 36.46%
Top 10 Holdings 52.78%
Top 25 Holdings 88.52%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 68.96
Healthcare 26.14
Chemicals 3.59
Cash 1.31
 
 
 
 
 
Portfolio Metrics
PB Ratio 6.58
PE Ratio 50.85
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Ltd. 13.21
Divis Laboratories Ltd. 9.35
Molbio Diagnostics Limited 5.08
Torrent Pharmaceuticals Ltd. 4.65
ACUTAAS CHEMICALS LIMITED 4.17
Max Healthcare Institute Limited 3.61
Cipla Ltd. 3.26
PARK MEDI WORLD LIMITED 3.17
Gland Pharma Limited 3.16
YATHARTH HOSPITAL & TRAUMA CARE SERVICES LIMITED 3.12
Triparty Repo 3.01
Apollo Hospitals Enterprises Ltd. 2.97
Sai Life Sciences Limited 2.96
Laurus Labs Limited 2.88
Mankind Pharma Limited 2.73
Krishna Institute of Medical Sciences Limited 2.71
Marksans Pharma Ltd. 2.44
Anthem Biosciences Limited 2.34
Fortis Healthcare Ltd 2.33
PRASOL CHEMICALS LIMITED 2.24
Ajanta Pharma Ltd. 1.97
RUBICON RESEARCH LIMITED 1.96
Emcure Pharmaceuticals Limited 1.77
Aurobindo Pharma Ltd. 1.72
VIYASH SCIENTIFIC LIMITED 1.71

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-3.26% 0.39% 17.48% 20.15%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
-2.23% -2.98% 8.71% 8.99%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
11.01% 0.00% 0.00% 0.00%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
6.75% 21.05% 14.18% 10.60%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Kotak Healthcare Fund Reg (G) 0.00% 0.0000 0.0000% 0.0000 0.0000
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Kotak Healthcare Fund Reg (G) 0.0000% 0.0000 0.0000 0.0000 0.0000
 
Back to Selection